Join Emeritus Professor Robert Clancy AM to learn about the 35 years of ground-breaking scientific work behind the development of an effective oral vaccine for Chronic Obstructive Pulmonary Disease (COPD), previously called Emphysema, and how it has re-shaped the way we consider this disease — and many like it such as bronchiectasis, cystic fibrosis, and late onset asthma.
Chronic Obstructive Pulmonary Disease (COPD) affects 20% of the population. It is the third most common cause of death — and the only major cause that is increasing.
Many in the medical profession still hold the unacceptable view that COPD is an irreversible, untreatable, self-induced disease: “It’s your own fault. Stop smoking.” The cost to person and public purse is beyond thinking.
The bottom line is that damaged airways become home to bacteria not usually there, and a “second phase” perpetuates the disease long after the initial cause, such as smoking, has gone. The disease process becomes a struggle between the bacteria, intercurrent virus infection, and the way the body reacts to control colonisation of the damaged airways by bacteria. Indeed, it is this host response that causes the damage — and this can be controlled by a very simple vaccine.
No Bookings Required
FREE & Open to the Public
About this talk
Professor Clancy will discuss:
- the novel ways that the airways are protected to ensure their function of gas exchange is not compromised, using “drop-in immunity on an as needed basis”;
- why those with COPD have acute flares (which is what does the damage); and
- how this knowledge translates into a simple safe and cheap vaccine, that improves day to day symptoms and reduces acute exacerbations and their sequelae such as admission into hospital.